GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jin Yang Pharmaceutical Co Ltd (XKRX:007370) » Definitions » Cyclically Adjusted Price-to-FCF

Jin Yang Pharmaceutical Co (XKRX:007370) Cyclically Adjusted Price-to-FCF : (As of Jun. 11, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Jin Yang Pharmaceutical Co Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Jin Yang Pharmaceutical Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Jin Yang Pharmaceutical Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jin Yang Pharmaceutical Co Cyclically Adjusted Price-to-FCF Chart

Jin Yang Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Jin Yang Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Jin Yang Pharmaceutical Co's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Jin Yang Pharmaceutical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jin Yang Pharmaceutical Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jin Yang Pharmaceutical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Jin Yang Pharmaceutical Co's Cyclically Adjusted Price-to-FCF falls into.



Jin Yang Pharmaceutical Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Jin Yang Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Jin Yang Pharmaceutical Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=245.989/118.8477*118.8477
=245.989

Current CPI (Mar. 2024) = 118.8477.

Jin Yang Pharmaceutical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -237.019 99.353 -283.526
201409 -40.569 99.608 -48.405
201412 -158.921 99.098 -190.593
201503 -91.917 99.720 -109.548
201506 -367.424 100.050 -436.457
201509 -409.574 100.110 -486.234
201512 -707.134 100.220 -838.568
201603 -135.651 100.560 -160.320
201606 97.712 100.790 115.218
201609 -2,120.013 101.460 -2,483.330
201612 -118.726 101.560 -138.936
201703 -62.718 102.850 -72.473
201706 58.161 102.610 67.365
201709 -101.636 103.490 -116.719
201712 -82.709 102.990 -95.444
201803 14.942 104.100 17.059
201806 57.598 104.130 65.739
201809 60.064 105.650 67.567
201812 -67.891 104.350 -77.323
201903 148.454 104.490 168.853
201906 89.387 104.880 101.291
201909 186.379 105.200 210.558
201912 142.932 105.120 161.598
202003 -27.619 105.540 -31.102
202006 111.111 104.870 125.921
202009 93.069 106.200 104.153
202012 259.381 105.765 291.464
202103 48.438 107.357 53.622
202106 169.701 107.579 187.478
202109 11.494 108.759 12.560
202112 -296.801 109.676 -321.620
202203 366.819 111.806 389.922
202206 -63.705 114.083 -66.366
202209 -85.061 114.831 -88.036
202212 70.579 115.200 72.814
202303 142.445 116.550 145.254
202306 39.420 117.140 39.995
202309 265.646 119.111 265.058
202312 111.703 118.848 111.703
202403 245.989 118.848 245.989

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Jin Yang Pharmaceutical Co  (XKRX:007370) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Jin Yang Pharmaceutical Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Jin Yang Pharmaceutical Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Jin Yang Pharmaceutical Co (XKRX:007370) Business Description

Traded in Other Exchanges
N/A
Address
1532-9 Seocho-3 dong, Seocho-gu, Seoul, KOR, 137-073
Jin Yang Pharmaceutical Co Ltd is a drug manufacturer in South Korea. The products of the company are bonid, carnit, livera, ganatiran, megaton, and magtin.

Jin Yang Pharmaceutical Co (XKRX:007370) Headlines

No Headlines